SNAP-8 Bulk Supplier — Canada
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports SNAP-8 (CAS: 868844-74-0) to research institutions in Canada. Our WHO-GMP certified facility in India supplies 98%+ purity SNAP-8 for acetylcholine receptor antagonism and wrinkle research.
SNAP-8 Export Specifications for Canada
| Compound | SNAP-8 |
| CAS Number | 868844-74-0 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | Health Canada |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to Canada | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of SNAP-8
SNAP-8 is used in acetylcholine receptor antagonism and wrinkle research. Research institutions in Canada source this compound for preclinical studies under applicable Health Canada research regulations.
Why Canada Researchers Source SNAP-8 from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for Health Canada compliance
- Temperature-controlled DHL/FedEx shipping to Canada
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in Canada
Semaglutide in Canada | Tirzepatide in Canada | Retatrutide in Canada | Liraglutide in Canada
SNAP-8 — Other Countries
SNAP-8 in USA | SNAP-8 in UK | SNAP-8 in Germany | SNAP-8 in Australia
Source from India — Key Manufacturing Cities
SNAP-8 in Mumbai, India | SNAP-8 in Delhi, India | SNAP-8 in Hyderabad, India | SNAP-8 in Bangalore, India
Request SNAP-8 for your Canada research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
